产品中心 流式试剂&相关 流式抗体

所有图片(1/3)

Rat Anti-Mouse PD-1 (CD279) Antibody (S-R496)

Programmed cell death protein 1,Protein PD-1,mPD-1,CD279,Pd1,Pdcd1

价格 600.00 1-2周
货号 S0B5182
规格
数量
收藏 分享

产品介绍 评论(0)

产品规格
  • 宿主来源

    Rat
  • 抗原名称

    PD-1 (CD279)
  • 分子别名

    Programmed cell death protein 1; Protein PD-1; mPD-1; CD279; Pd1; Pdcd1
  • 细胞定位

    Cell membrane
  • Accession

    Q02242
  • 克隆号

    S-R496
  • 抗体类型

    Rat mAb
  • 抗体同种型

    IgG2a
  • 同型对照

    S0B0932
  • 反应种属 ?

    Ms
  • 阳性样本

    EL4.IL-2
  • 纯化方式

    Protein G
  • 浓度

    2 mg/ml
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS pH7.4

  • 储存条件

    12 months from date of receipt / reconstitution, 2 to 8 °C as supplied

  • 应用

    FCM

    WB

  • 稀释度

    应用 稀释度 推荐种属
    WB 1:1000 Ms
    FCM 1:2000 Ms
背景介绍
  • Programmed cell death protein 1 (PD-1), also known as CD279, is a type I transmembrane protein and a member of the CD28 immunoglobulin superfamily, encoded by the _PDCD1_ gene. It is primarily expressed on the surface of various immune cells, including T cells, B cells, macrophages, dendritic cells, and natural killer cells. PD-1 plays a crucial role in regulating immune responses by binding to its ligands, PD-L1 (B7-H1) and PD-L2 (B7-DC), which are expressed on antigen-presenting cells and tumor cells. When PD-1 interacts with its ligands, it triggers inhibitory signals that downregulate T cell activity, preventing excessive immune responses and promoting self-tolerance. However, this pathway can also be exploited by cancer cells to evade immune surveillance, leading to tumor progression. As a result, PD-1 has become a key target in cancer immunotherapy, with several anti-PD-1 antibodies approved for treating various cancers, achieving significant and durable efficacy in some patients.

  • 免疫印迹

    • WB result of Rat Anti-Mouse PD-1 (CD279) Antibody
      Primary antibody: Rat Anti-Mouse PD-1 (CD279) Antibody at 1/1000 dilution
      Lane 1: recombinant PD-1 Fc Chimera 10 ng
      Secondary antibody: Goat Anti-Rat IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 32 kDa
      Observed MW: 55-70 kDa

    • WB result of Rat Anti-Mouse PD-1 (CD279) Antibody
      Primary antibody: Rat Anti-Mouse PD-1 (CD279) Antibody at 1/1000 dilution
      Lane 1: NIH/3T3 whole cell lysate 20 µg
      Lane 2: EL4.IL-2 whole cell lysate 20 µg
      Negative control: NIH/3T3 whole cell lysate
      Secondary antibody: Goat Anti-Rat IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 32 kDa
      Observed MW: 40-55 kDa

  • 流式分析

    • Flow cytometric analysis of NIH/3T3 (Mouse embryonic fibroblast, Left) / EL4.IL-2 (Mouse lymphoma T lymphocyte, Right) labelled with anti-Mouse PD-1 (CD279) antibody at 1/2000 dilution (0.1 μg) / (Red) compared with a Rat IgG2a (Black) Isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). Goat Anti - Rat IgG Alexa Fluor® 488 was used as the secondary antibody.
      Negative control: NIH/3T3

评论(0)